Cheng Qian

机构：Nanjing University of Chinese Medicine, Harbin Medical University, Third Affiliated Hospital of Harbin Medical University · ORCID：0000-0001-9852-2285

发表论文 25 篇 · 总被引 698 次 · h-index 15

代表论文

• Advance in the pharmacological effects of quercetin in modulating oxidative stress and inflammation related disorders (2023 · Phytotherapy Research · 被引 81)
• Ginseng polysaccharides ameliorate ulcerative colitis via regulating gut microbiota and tryptophan metabolism (2024 · International Journal of Biological Macromolecules · 被引 69)
• MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis (2022 · Experimental & Molecular Medicine · 被引 61)
• Pharmacological manipulation of Ezh2 with salvianolic acid B results in tumor vascular normalization and synergizes with cisplatin and T cell-mediated immunotherapy (2022 · Pharmacological Research · 被引 61)
• Targeting PKM2 signaling cascade with salvianic acid A normalizes tumor blood vessels to facilitate chemotherapeutic drug delivery (2024 · Acta Pharmaceutica Sinica B · 被引 49)
• Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade (2022 · Frontiers in Immunology · 被引 48)